Stay updated on Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Sign up to get notified when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.

Latest updates to the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record for the pediatric type 2 diabetes trial is now displayed, with details about study methods, results measures, participant eligibility, locations, and data-sharing resources.SummaryDifference100%

- Check18 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces NIH website updates and links to transition FAQs, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check31 days agoChange DetectedThe site footer revision marker changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal HTML header and a Home link. This indicates that access to the requested resource is blocked.SummaryDifference0.5%

Stay in the know with updates to Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.